Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label phase 3 study of MDMA-assisted individual and group psychotherapy for military-related PTSD in Duvdevan unit veterans
MOH_2023-02-19_012309Phase 3Recruiting
- Sponsor
- ד"ר גיא שוסהיים
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of midomafetamine in post-traumatic stress disorder (PTSD) (2 arms), sponsored by ד"ר גיא שוסהיים. Started Feb 2023; status: recruiting.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on MOH_2023-02-19_012309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-02-19_012309.